RecruitingNot ApplicableNCT07129226

Musculoskeletal Cancers Remote Monitoring and Care

Sponsor

Case Comprehensive Cancer Center

Enrollment

60 participants

Start Date

Feb 11, 2026

Study Type

INTERVENTIONAL

Conditions

Osteosarcoma Metastatic Bone Disease

Summary

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
undergoing evaluation for radiological or surgical intervention.
recent Karnofsky Performance Status (KPS) ≥ 70% at baseline.

Exclusion Criteria6

under 18 years of age at the time of study enrolment
inability to comprehend consent form and give informed consent
no access to a smartphone (iOS or Android) to interface with watch application
tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function
amputation or other disease of the arm or skin that prevents wear of a smart-watch device
inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period

Interventions

OTHERSmart Watch

Participants will be asked to wear the smartwatch daily, for at least 12 hours per day during the 12-week study period, with breaks to recharge the watch as needed.